Morepen Laboratories Ltd.
Snapshot View

23.90 -0.45 ▼-1.9%

30 September 2022, 04:01:00 PM
Volume: 1,176,094

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.morepen.com
Market Cap 1,221.69 Cr.
Enterprise Value(EV) 1,194.29 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.50 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 15.90 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 13.75 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.74 Calculated using Price: 23.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 51.12 Cr. 511,168,708 Shares
FaceValue 2
Company Profile
Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.85%
1 Week
-23.76%
1 Month
-30.62%
3 Month
-38.24%
6 Month
-36.60%
1 Year
-57.81%
2 Year
-2.65%
5 Year
+50.31%
10 Year
+547.70%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -1.54 1.24 7.35 12.54 14.10 12.04 12.50 29.20 21.79
Return on Capital Employed (%) 1.80 2.90 6.29 10.18 14.05 10.01 12.05 27.13 24.86
Return on Assets (%) -0.55 0.44 2.53 4.45 5.30 4.80 5.25 12.76 10.55

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 300 297 287 300 196 226 253 284 425 579
Non Curr. Liab. 104 85 74 57 18 20 23 28 30 36
Curr. Liab. 103 108 128 167 325 340 339 351 404 456
Minority Int. 0 0 0 -1 -1 0 0 0 0 0
Equity & Liab. 506 490 489 524 538 586 615 663 858 1,070
Non Curr. Assets 415 393 374 367 346 342 316 291 331 336
Curr. Assets 91 96 115 157 192 243 299 372 527 734
Misc. Exp. not W/O
Total Assets 506 490 489 524 538 586 615 663 858 1,070

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 367 401 485 595 607 769 853 1,188 1,547 1,463
Other Income 1 1 1 4 4 4 9 12 20 10
Total Income 368 402 486 599 610 772 863 1,200 1,567 1,472
Total Expenditure -318 -352 -424 -534 -542 -701 -785 -1,070 -1,410 -1,355
PBIDT 50 50 63 65 68 71 78 131 157 117
Interest -10 -9 -11 -8 -4 -2 -2 -2 -2 7
Depreciation -46 -39 -35 -34 -34 -40 -37 -30 -28 -28
Taxation 0 0 0 0 -6 -1 -25 -20
Exceptional Items 3 -4
PAT -3 2 13 24 30 29 34 97 102 77
Minority Interest 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit -3 2 13 24 30 29 34 97 102 77
Adjusted EPS 0 0 0 1 1 1 1 2 2 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 34 51 50 41 63 17 11 51 -58
Cash Fr. Inv. -3 -1 -32 -27 -14 -27 -13 -12 -70 -32
Cash Fr. Finan. -30 -29 -19 -27 -24 -38 0 5 47 64
Net Change 1 4 0 -4 3 -1 4 4 28 -26
Cash & Cash Eqvt 6 9 9 4 7 6 10 14 41 16

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 34.54 34.54 34.54 34.54 34.54 34.54 34.54 38.38 36.74
Public 65.46 65.46 65.46 65.46 65.46 65.46 65.46 61.62 63.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 30 Sep 2022
Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in accordance with the Code of Conduct to Regulate Monitor and Report of Trading by Insiders for trading in the companys shares/ securities the trading window will remain closed with effect from October 01 2022 for the purpose of consideration and approval of unaudited financial results for the quarter and half year ended September 30 2022.
Wed, 28 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This is to inform that 37th Annual General Meeting (AGM) of Morepen Laboratories Limited (the company) was held on Tuesday September 27 2022 through video conferencing/ other audio-visual means.Mr. Praveen Dua Proprietor of PD and Associates Practising Company Secretaries was appointed as the Scrutinizer to scrutinize the voting process in fair and transparent manner. The consolidated Scrutinizers Report dated September 27 2022 is attached herewith as Annexure-I.In terms of the provisions of Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 the details of voting results are also attached herewith as Annexure-II.
Tue, 27 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 as amended we would like to inform you that 37th Annual General Meeting of Morepen Laboratories Limited (Company) was held today i.e. Tuesday September 27 2022 through Video Conferencing/Other Audio-Visual Means.The proceeding of the said meeting is annexed herewith.

Technical Scans View Details >>

Fri, 30 Sep 2022
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 949.00 +2.0%
Divi's Laboratories Ltd. 97,811.90 3,684.50 -0.2%
Cipla Ltd. 89,996.82 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. 52,506.43 1,551.40 +0.3%
Abbott India Ltd. 40,438.70 19,030.60 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 36.17 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 50.01 19,030.60 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 4.19 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 13.56 19,030.60 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,030.60 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 19,030.60 -0.8%

FAQ's On Morepen Laboratories Ltd.

What is Morepen Laboratories share price?

Can I buy Morepen Laboratories shares now?

What is the Market Cap of Morepen Laboratories?

What are the key metrics to analyse Morepen Laboratories?

What is the 52 Week High and Low of Morepen Laboratories?

What is the trend of Morepen Laboratories share price?